124 related articles for article (PubMed ID: 30455566)
1. Prolonged complete remission in a primary MALT lymphoma of the lung after rituximab monotherapy.
Diamantidis MD; Chatzileontiadou S; Pantelidou D; Papaioannou M
Hippokratia; 2017; 21(2):108-110. PubMed ID: 30455566
[TBL] [Abstract][Full Text] [Related]
2. A single center experience: rituximab plus cladribine is an effective and safe first-line therapy for unresectable bronchial-associated lymphoid tissue lymphoma.
Wei Z; Li J; Cheng Z; Yuan L; Liu P
J Thorac Dis; 2017 Apr; 9(4):1081-1092. PubMed ID: 28523163
[TBL] [Abstract][Full Text] [Related]
3. Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma of the Colon: A Case Report and a Literature Review.
Abbas H; Niazi M; Makker J
Am J Case Rep; 2017 May; 18():491-497. PubMed ID: 28469125
[TBL] [Abstract][Full Text] [Related]
4. Rituximab monotherapy as a first-line treatment for pulmonary mucosa-associated lymphoid tissue lymphoma.
Okamura I; Imai H; Mori K; Ogura K; Isoda A; Mihara K; Matsumoto M; Saito R; Takahashi T; Ikeda T
Int J Hematol; 2015 Jan; 101(1):46-51. PubMed ID: 25378228
[TBL] [Abstract][Full Text] [Related]
5. Rituximab for treatment of advanced extranodal marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue lymphoma.
Raderer M; Jäger G; Brugger S; Püspök A; Fiebiger W; Drach J; Wotherspoon A; Chott A
Oncology; 2003; 65(4):306-10. PubMed ID: 14707449
[TBL] [Abstract][Full Text] [Related]
6. Synchronous Pulmonary Neoplasms: A Chance Occurrence or is There More Than Meets the Eye?
Ibrahim U; Saqib A; Pant M; Garcia G; Odaimi M
Cureus; 2018 Feb; 10(2):e2162. PubMed ID: 29651368
[TBL] [Abstract][Full Text] [Related]
7. Rituximab, alkylating agents or combination therapy for gastric mucosa-associated lymphoid tissue lymphoma: a monocentric non-randomised observational study.
Amiot A; Lévy M; Copie-Bergman C; Dupuis J; Szablewski V; Le Baleur Y; Baia M; Belhadj K; Sobhani I; Leroy K; Haioun C; Delchier JC
Aliment Pharmacol Ther; 2014 Mar; 39(6):619-28. PubMed ID: 24467480
[TBL] [Abstract][Full Text] [Related]
8. MALT lymphoma of the left biceps muscle: a rare case with an interesting presentation.
Yonal-Hindilerden I; Hindilerden F; Dogan IO; Nalcaci M
Springerplus; 2016; 5(1):1194. PubMed ID: 27516932
[TBL] [Abstract][Full Text] [Related]
9. Transformation of Hodgkin's disease to high-grade B-cell lymphoma: remission after Rituximab monotherapy.
Kirchner EM; Ebsen M; Kirchner J; Theegarten D; Voigtmann R
Ann Oncol; 2001 Aug; 12(8):1169-71. PubMed ID: 11583202
[TBL] [Abstract][Full Text] [Related]
10. The discovery and the development of bendamustine for the treatment of non-Hodgkin lymphoma.
Munakata W; Tobinai K
Expert Opin Drug Discov; 2016 Nov; 11(11):1123-1130. PubMed ID: 27598460
[TBL] [Abstract][Full Text] [Related]
11. [Successful rituximab monotherapy in a patient with mucosa-associated lymphoid tissue lymphoma of the rectum with trisomy 3, 18].
Kagawa M; Okamura S; Okamoto K; Kitamura S; Kimura T; Niki M; Kaji M; Okahisa T; Yano M; Kagawa S; Kudo E; Sano T; Imoto Y; Wada S; Takayama T
Nihon Shokakibyo Gakkai Zasshi; 2010 Apr; 107(4):612-9. PubMed ID: 20379095
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of primary thyroid non-Hodgkin's lymphoma: a series of nine consecutive cases.
Colović M; Matić S; Kryeziu E; Tomin D; Colović N; Atkinson HD
Med Oncol; 2007; 24(2):203-8. PubMed ID: 17848745
[TBL] [Abstract][Full Text] [Related]
13. Results of Upfront Therapy for Marginal Zone Lymphoma.
Ortega JL; Cabanillas F; Rivera N; Tirado-Gomez M; Hallman D; Pardo WI; Bruno M
Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):879-883. PubMed ID: 29042174
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of lung cancer coexisting with B‑cell lymphoma with pembrolizumab following rituximab‑included chemotherapy: A case report.
Natori D; Ozasa H; Shima Y; Mizumoto C; Suminaga K; Nomizo T; Ajimizu H; Yoshida H; Hirai T
Mol Clin Oncol; 2024 Apr; 20(4):33. PubMed ID: 38476337
[TBL] [Abstract][Full Text] [Related]
15. Relapsed/refractory pediatric B-cell non-Hodgkin lymphoma treated with rituximab combination therapy: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group.
Osumi T; Mori T; Fujita N; Saito AM; Nakazawa A; Tsurusawa M; Kobayashi R
Pediatr Blood Cancer; 2016 Oct; 63(10):1794-9. PubMed ID: 27314926
[TBL] [Abstract][Full Text] [Related]
16. A case of conjunctival MALT lymphoma: successfully treated with solely extended rituximab therapy.
Celiker H; Toker E; Kaygusuz Atagunduz I
Int Ophthalmol; 2019 Mar; 39(3):687-691. PubMed ID: 29411260
[TBL] [Abstract][Full Text] [Related]
17. Extranodal marginal zone B-cell lymphoma of the lung: experience with fludarabine and mitoxantrone-containing regimens.
Zinzani PL; Pellegrini C; Gandolfi L; Casadei B; Derenzini E; Broccoli A; Quirini F; Argnani L; Pileri S; Celli M; Fanti S; Poletti V; Stefoni V; Baccarani M
Hematol Oncol; 2013 Dec; 31(4):183-8. PubMed ID: 23212941
[TBL] [Abstract][Full Text] [Related]
18. Transition of thyroid autoantibodies by rituximab treatment for thyroid MALT lymphoma.
Kahara T; Iwaki N; Kaya H; Kurokawa T; Yoshida T; Ishikura K; Usuda R
Endocr J; 2011; 58(1):7-12. PubMed ID: 21068513
[TBL] [Abstract][Full Text] [Related]
19. Safety and activity of the anti-CD79B antibody-drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study.
Palanca-Wessels MC; Czuczman M; Salles G; Assouline S; Sehn LH; Flinn I; Patel MR; Sangha R; Hagenbeek A; Advani R; Tilly H; Casasnovas O; Press OW; Yalamanchili S; Kahn R; Dere RC; Lu D; Jones S; Jones C; Chu YW; Morschhauser F
Lancet Oncol; 2015 Jun; 16(6):704-15. PubMed ID: 25925619
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of primary gastric lymphoma].
Xia Y; Zhou Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Nov; 20(11):1227-1230. PubMed ID: 29178090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
